- Learn the basics
- Find stocks
- Understand a stock
- Compare with peers
EUPRAXIA PHARMACEUTICALS INC.
EPRX United States NASDAQEupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidates are EP-104IAR, which is in a Phase III clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis; EP-104GI, which is in a Phase II clinical trial for the treatment of eosinophilic esophagitis; and EP-104, under preclinical studies for the treatment of other inflammatory joint conditions, benign structures of the esophagus, and epidural delivery. It also is involved in the development of product candidates for oncology. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.
In short
Loading the key numbers…
What the sector means for this company
These sentences describe the numbers; they are not a recommendation. This content is not investment advice.
Price chart: each candle shows one day's opening, highest, lowest and closing price. The projection line is our model's estimate - a model, not a promise.
Price chart
The bars show each projection's high and low scenario. The more likely an outcome, the more solid its half of the bar: for the DCF, how often 400 simulations of the company's growth and margins reach that scenario; for the growth plans, up means the plans succeed and no expected decline hits, down means the plans fail and the declines hit. Switch them off with Ranges.
Key statistics: the most used ratios in one place. Tap the icon next to a name for a short explanation. Compare them with similar companies, not with the whole market.
Financial statements: the income statement shows sales and profit, the balance sheet what the company owns and owes, and the cash flow statement the money that actually came in and went out. How to read them.
Company policy and leadership: an AI-assisted assessment of how the company sells, executes, uses its resources and treats people, production and service. Read it as a starting point for your own research.
News: the latest articles about the company, grouped by day. Each has ratings for the outlet's stance towards the company, how factual it is and the market mood it conveys (an animal label such as Bull or Bear - hover it for the meaning). What the ratings mean.
More Health Care stocks
- enVVeno Medical Corp (NVNO)
- Equillium, Inc. (EQ)
- Erasca, Inc. (ERAS)
- Ernexa Therapeutics Inc. (ERNA)
- Ernexa Therapeutics Inc. (ERNAW)
- Esperion Therapeutics, Inc. (ESPR)
- Establishment Labs Holdings Inc. (ESTA)
- Estrella Immunopharma, Inc. (ESLA)
- Estrella Immunopharma, Inc. (ESLAW)
- Eton Pharmaceuticals, Inc. (ETON)
- EUDA Health Holdings Ltd (EUDA)
- EUDA Health Holdings Ltd (EUDAW)
- Evaxion A/S (EVAX)
- Evolus, Inc. (EOLS)
- Evommune, Inc. (EVMN)
- Evotec SE (EVO)
- Exagen Inc. (XGN)
- Exelixis, Inc. (EXEL)
- Exicure, Inc. (XCUR)
- Exozymes Inc. (EXOZ)
- EyePoint, Inc. (EYPT)
- Faeth Therapeutics, Inc. (FTH)
- Fate Therapeutics Inc (FATE)
- Femasys Inc (FEMY)